HER2 therapies and gastric cancer: A step forward
2013 · World Journal of Gastroenterology · 49 citations
https://doi.org/10.3748/wjg.v19.i37.6165
R
Ramon Andrade de Mello
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
210
Papers
2.4K
Citations
27
h-index
55
i10-index
Ramon Andrade de Mello is an academic researcher from University of Crete. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers & Lung Cancer Research Studies. The author has an h-index of 27, co-authored 179 publications.
ORCID: 0000-0002-9640-4573Papers by this author
worksImmune checkpoint inhibitors for advanced non-small cell lung cancer: emerging sequencing for new treatment targets
2017 · ESMO Open · 40 citations
https://doi.org/10.1136/esmoopen-2017-000200
Targeting HER Family in HER2-Positive Metastatic Breast Cancer: Potential Biomarkers and Novel Targeted Therapies
2015 · Pharmacogenomics · 29 citations
https://doi.org/10.2217/pgs.14.133
The Impact of Polymorphic Variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the Risk and Prognosis of Portuguese Patients with Non-Small Cell Lung Cancer
2013 · PLoS ONE · 29 citations
https://doi.org/10.1371/journal.pone.0072373
Prognostic value of ferroptosis‐related genes in patients with lung adenocarcinoma
2021 · Thoracic Cancer · 21 citations
https://doi.org/10.1111/1759-7714.13998
The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC
2017 · Annals of Oncology · 12 citations
https://doi.org/10.1093/annonc/mdx478
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat